Proven medical device and health technology experts will show you how to improve your sales & marketing efforts, enhance your regulatory submissions, raise venture capital, and much more.


Check out the most recent interviews with world-class medical device and health technology founders and CEOs.

Go Premium

Balancing the Clinical-Commercial Tightrope

Interview with Mercator MedSystems CEO Trent Reutiman

Trent Reutiman has 25 years of leadership experience in medtech with a particular focus on minimally invasive interventional therapies. As the CEO of Mercator, Trent and his team have developed microinfusion devices with the unique ability to locally and directly deliver targeted therapeutics during catheter-based interventions where mechanical therapy isn’t sufficient. In this interview, Trent talks about the importance of generating data, how to balance commercial efforts with clinical initiatives, and why meticulous management is critical for successful commercialization.


Don’t Build A Unicorn, Build A Useful Zebra

Interview with DeepLook CEO Marissa Fayer

Marissa Fayer, with over two decades of experience in the medtech sector, is the CEO of DeepLook Medical, developers of AI-powered diagnostic tools that help radiologists detect cancerous lesions in dense tissue. In this interview, Marissa talks about the basics of product development, how to build iteratively, tips on identifying ideal regulatory pathways, and how she picks her advisors and board members.


Managing to a Successful Acquisition

Interview with LimFlow CEO Dan Rose

Dan Rose’s career in medtech features pivotal roles at Direct Flow, Sequana Medical, and Medtronic, culminating in his position as CEO of LimFlow, which recently exited to Inari Medical. In this interview, Dan shares his extensive wisdom on M&A transactions, engaging with investors while maintaining business autonomy, the importance of developing with the ‘average user’ in mind, and the significance of early dialogue with regulatory bodies.


How to Run Your Medtech Startup on a Budget

Interview with Syntr Health CEO Ahmed Zobi

Ahmed Zobi, founder and CEO of Syntr Health Technologies, and his team have developed an automated microfat processing system for use in aesthetics and plastic surgery. The FDA-cleared SyntrFuge device allows clinicians to harvest patients’ adipose tissue and then reinject it as processed microfat within minutes into the desired area, eliminating the use of fillers. SynterFuge has the potential to be applied in other fields like wound care, orthopedics, podiatry, dermatology, and many more. In this interview, Ahmed shares his ideas on the risks and rewards of entrepreneurship, how to operate in a lean fashion, why he puts regulatory clearance above all, and how he managed to be the youngest candidate to ever receive a phase 1 SBIR grant.


Finding Your Place in the Healthcare Ecosystem

Interview with Vivante Health CEO Bill Snyder

Bill Snyder, CEO of Vivante Health, and his team are commercializing an all-in-one digital platform for digestive health conditions. GIThrive is a platform that combines data-driven technology with a team of physicians, registered dietitians, and health coaches to deliver personalized care. In this interview, Bill talks about the importance of finding where your company stands in the overall healthcare ecosystem, why clinical outcomes and sorting out reimbursement are critical to survival, and his experiences raising capital for Vivante.


Crowdfunding and IPOs for Medtech Startups

Interview with Monogram Orthopedics CEO Benjamin Sexson

Benjamin Sexson is the President and CEO of Monogram Orthopedics. He is a mechanical engineer from Caltech and a CFA charterholder. At Monogram, Ben and his team are developing a fully autonomous robotic system for knee replacement surgery. In this interview, Ben talks about the importance of a good team and a liberating company culture as well as the importance of believing in what you’re doing and openly reassessing its validity regularly. He also elaborates on Monogram’s daring strategies for validating its technology and walks us through the pros and cons of crowdfunding and going public.


Get exclusive benefits like full access to the entire archive of Medsider interviews and every Medsider Mentors volume.

Go Premium

How to Innovate in Medtech with Limited Means

Interview with Field Medical CEO Dr. Steven Mickelsen

Dr. Steven Mickelsen is a practicing electrophysiologist who’s leveraging his clinical expertise and entrepreneurial spirit to revolutionize cardiac care. He made significant strides ushering in pulse field ablation (PFA) technology into the field through one of his previous companies Farapulse, which sold to Boston Scientific. Today, as CEO of Field Medical, he continues to contribute to the space by developing the next generation of PFA for ventricular arrhythmia management. In this episode, he shares his hard-earned wisdom on how limited means can breed resourcefulness, how to build a modest yet effective prototype, why having real expertise in clinical and regulatory spheres is a necessity, and how to raise funds with a win-win mindset.


Grit and the Power of Showing Up

Interview with Venture Capitalist Anish Kaushal

Anish Kaushal, a former physician turned healthcare investor and author, shares his unconventional career journey from medicine to VC at Amplitude Ventures. He reveals vital fundraising strategies from an investor's perspective, offers practical tips for crafting pitch decks that capture attention, discusses why always being in the mode of seeking funds is so important, expands on the value of building extensive networks, and talks about the cumulative effect of small improvements. He also provides guidance on staying open and ready for career shifts in today’s fast-paced professional environment as outlined in his latest book.


The Essentials of Building the Right Foundation

Interview with Neuro42 Co-Founder Abhita Batra

Abhita Batra, co-founder and Chief Strategy Officer at Neuro42, is at the forefront of altering neurological diagnostics for good. The company recently received 510(k) clearance for its portable head and brain MRI system, which integrates MRI, AI, and robotics in one platform. Neuro42's system is a compact, easy-to-use solution for urgent care and clinical settings. In this interview, Abhita talks about her approach to building strategy at early-stage companies, the importance of a good team and thorough market analysis, and how to take a nuanced approach with regulatory bodies.


Empathy-Driven Innovation

Interview with MOLLI Surgical CEO Ananth Ravi

Under the guidance of Ananth Ravi, MOLLI Surgical has developed an award-winning, wire-free soft tissue localization technology for breast cancer surgery. Their device, MOLLI, precisely marks the location of lesions for removal during surgery and is setting a new standard for patient comfort compared to traditional methods. In this interview, Ananth unpacks his story, touching upon the benefits of being in close contact with a medical ecosystem, the importance of intuitive design, the ideal role of regulatory consultants, and the funding strategies he employs for MOLLI.


Think Big, Start Small, and Prioritize Ruthlessly

Interview with InterShunt CEO Harlee Sorkin

Harlee Sorkin’s company, InterShunt Technologies, is leading the development of a groundbreaking minimally invasive catheter designed to treat heart failure. The technique they use focuses on creating a shunt within the heart. By improving blood flow and lessening the heart's workload, it holds promise of easing heart failure symptoms, potentially setting a new standard in patient care. In this interview, Harlee delves into the nuances of leading an early-stage medtech company and covers essential topics such as development prioritization and capital fundraising. He also shares what it’s like to navigate clinical and regulatory challenges as a first-time medtech entrepreneur and how to effectively engage with stakeholders across the healthcare ecosystem.


Why Learning Fast Beats Failing Fast

Interview with Portal Instruments CEO Patrick Anquetil

Patrick Anquetil, CEO of Portal Instruments, has extensive experience in guiding bioengineering companies from their nascent stages to market success. At Portal, they are developing a novel needle-free drug delivery system. This cutting-edge technology promises to revolutionize how medications are administered, making the process less invasive, more precise, and more comfortable for patients. In this interview, Patrick talks about how he landed on Portal’s business model, how his team condenses timelines across key company functions, and why their diverse set of partners is a golden asset to the company.


Taking the Stress Out of Conception

Interview with Béa Fertility CEO Tess Cosad

We sat down with Tess Cosad, a femtech enthusiast and CEO of Béa Fertility. Founded in 2020, Béa offers innovative, hormone-free, accessible, at-home fertility treatments and ovulation tracking as an alternative to traditional clinic-based offerings. Their flagship product simplifies the fertility journey thanks to its user-friendly design. In this interview, Tess delves into the challenges and triumphs of launching a consumer-facing product, the importance of a solid design team, how to be comfortable making decisions with imperfect information, and the lessons she learned about being a CEO while raising funds.


Building a Startup in a Collaborative Ecosystem

Interview with Noa Therapeutics CEO Carla Spina

In this episode, we sit down with Carla Spina, the pioneering force behind Noa Therapeutics. Carla and her team are developing treatments for inflammatory skin diseases with their innovative multimodal small-molecule therapies. Carla shares her invaluable experiences on the importance of engaging actively with the startup ecosystem and staying connected with those who are shaping the field. We talk about how building a company is a collaborative venture that requires a strong network of entrepreneurs, investors, and industry experts, and the significance of authentic interaction when reaching out to a variety of potential stakeholders.